These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32464173)

  • 21. Mouse induced pluripotent stem cells-derived Alzheimer's disease cerebral organoid culture and neural differentiation disorders.
    Fan W; Sun Y; Shi Z; Wang H; Deng J
    Neurosci Lett; 2019 Oct; 711():134433. PubMed ID: 31421155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A simplified and sensitive method to identify Alzheimer's disease biomarker candidates using patient-derived induced pluripotent stem cells (iPSCs).
    Shirotani K; Matsuo K; Ohtsuki S; Masuda T; Asai M; Kutoku Y; Ohsawa Y; Sunada Y; Kondo T; Inoue H; Iwata N
    J Biochem; 2017 Dec; 162(6):391-394. PubMed ID: 28992104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opportunities and Limitations of Modelling Alzheimer's Disease with Induced Pluripotent Stem Cells.
    Ovchinnikov DA; Wolvetang EJ
    J Clin Med; 2014 Dec; 3(4):1357-72. PubMed ID: 26237606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Important advances in Alzheimer's disease from the use of induced pluripotent stem cells.
    Majolo F; Marinowic DR; Machado DC; Da Costa JC
    J Biomed Sci; 2019 Feb; 26(1):15. PubMed ID: 30728025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human iPSC-Derived Neural Models for Studying Alzheimer's Disease: from Neural Stem Cells to Cerebral Organoids.
    Barak M; Fedorova V; Pospisilova V; Raska J; Vochyanova S; Sedmik J; Hribkova H; Klimova H; Vanova T; Bohaciakova D
    Stem Cell Rev Rep; 2022 Feb; 18(2):792-820. PubMed ID: 35107767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness.
    Kondo T; Asai M; Tsukita K; Kutoku Y; Ohsawa Y; Sunada Y; Imamura K; Egawa N; Yahata N; Okita K; Takahashi K; Asaka I; Aoi T; Watanabe A; Watanabe K; Kadoya C; Nakano R; Watanabe D; Maruyama K; Hori O; Hibino S; Choshi T; Nakahata T; Hioki H; Kaneko T; Naitoh M; Yoshikawa K; Yamawaki S; Suzuki S; Hata R; Ueno S; Seki T; Kobayashi K; Toda T; Murakami K; Irie K; Klein WL; Mori H; Asada T; Takahashi R; Iwata N; Yamanaka S; Inoue H
    Cell Stem Cell; 2013 Apr; 12(4):487-96. PubMed ID: 23434393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human Pluripotent Stem Cell-Derived Neural Cells as a Relevant Platform for Drug Screening in Alzheimer's Disease.
    Garcia-Leon JA; Caceres-Palomo L; Sanchez-Mejias E; Mejias-Ortega M; Nuñez-Diaz C; Fernandez-Valenzuela JJ; Sanchez-Varo R; Davila JC; Vitorica J; Gutierrez A
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alzheimer's in a dish - induced pluripotent stem cell-based disease modeling.
    de Leeuw S; Tackenberg C
    Transl Neurodegener; 2019; 8():21. PubMed ID: 31338163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induced Pluripotent Stem Cell-Derived Astroglia: A New Tool for Research Towards the Treatment of Alzheimer's Disease.
    Atkinson-Dell R; Mohamet L
    Adv Exp Med Biol; 2019; 1175():383-405. PubMed ID: 31583596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3D bioprinting patient-derived induced pluripotent stem cell models of Alzheimer's disease using a smart bioink.
    Benwood C; Walters-Shumka J; Scheck K; Willerth SM
    Bioelectron Med; 2023 May; 9(1):10. PubMed ID: 37221543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sildenafil as a Candidate Drug for Alzheimer's Disease: Real-World Patient Data Observation and Mechanistic Observations from Patient-Induced Pluripotent Stem Cell-Derived Neurons.
    Gohel D; Zhang P; Gupta AK; Li Y; Chiang CW; Li L; Hou Y; Pieper AA; Cummings J; Cheng F
    J Alzheimers Dis; 2024; 98(2):643-657. PubMed ID: 38427489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human-Induced Pluripotent Stem Cell (hiPSC)-Derived Neurons and Glia for the Elucidation of Pathogenic Mechanisms in Alzheimer's Disease.
    Young JE; Goldstein LSB
    Methods Mol Biol; 2023; 2561():105-133. PubMed ID: 36399267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Being human: The role of pluripotent stem cells in regenerative medicine and humanizing Alzheimer's disease models.
    Sproul AA
    Mol Aspects Med; 2015; 43-44():54-65. PubMed ID: 26101165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease.
    Wu YY; Chiu FL; Yeh CS; Kuo HC
    Open Biol; 2019 Jan; 9(1):180177. PubMed ID: 30958120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3D culture models of Alzheimer's disease: a road map to a "cure-in-a-dish".
    Choi SH; Kim YH; Quinti L; Tanzi RE; Kim DY
    Mol Neurodegener; 2016 Dec; 11(1):75. PubMed ID: 27938410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease Phenotypes.
    Raja WK; Mungenast AE; Lin YT; Ko T; Abdurrob F; Seo J; Tsai LH
    PLoS One; 2016; 11(9):e0161969. PubMed ID: 27622770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induced Pluripotent Stem Cell (iPSC)-Based Neurodegenerative Disease Models for Phenotype Recapitulation and Drug Screening.
    Chang CY; Ting HC; Liu CA; Su HL; Chiou TW; Lin SZ; Harn HJ; Ho TJ
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32344649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased susceptibility to Aβ toxicity in neuronal cultures derived from familial Alzheimer's disease (PSEN1-A246E) induced pluripotent stem cells.
    Armijo E; Gonzalez C; Shahnawaz M; Flores A; Davis B; Soto C
    Neurosci Lett; 2017 Feb; 639():74-81. PubMed ID: 28034781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stem cell models of Alzheimer's disease: progress and challenges.
    Arber C; Lovejoy C; Wray S
    Alzheimers Res Ther; 2017 Jun; 9(1):42. PubMed ID: 28610595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Modeling neurological and psychiatric disorders in vitro using induced pluripotent stem cells: highlighting findings in Alzheimer's disease and schizophrenia].
    Hathy E; Kalman S; Apati A; Nemoda Z; Rethelyi JM
    Neuropsychopharmacol Hung; 2016 Dec; 18(4):188-198. PubMed ID: 28259862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.